Jamie Matusow, Editor-in-Chief11.02.15
Update: Johnson & Johnson ranks at #10 on our latest report Top 20 Global Beauty Companies 2021.
New Brunswick, NJ
www.jnj.com
Corporate Sales: $74.3 billion
Beauty Sales: $7.9 billion (skin care, baby care, oral care)
Key Personnel: Alex Gorsky, chairman, board of directors and chief executive officer; Dominic J. Caruso, chief financial officer; Jorge Mesquita, worldwide chairman, consumer.
Major Products/Brands: Neutrogena, Aveeno, Listerine, Johnson’s Baby, Dabao.
New Products: Aveeno Daily Moisturizing Sheer Hydration Lotion, Aveeno Baby Continuous Protection Lotion Sunscreen with Broad Spectrum SPF 55, Neutrogena Hydro Boost Water Gel, Neutrogena Healthy Skin Blush, Johnson’s Baby Head to Toe Wash, Johnson’s Baby Cologne, Listerine Naturals Rinse.
Comments: While primarily a pharmaceutical company, Johnson & Johnson’s select few consumer beauty brands are an additional shot in the arm for the New Jersey-based company—which scored the very healthy No. 6 slot on our Top 20 list.
Worldwide corporate sales for 2014 were $74.3 billion, a robust increase of 4.2% versus 2013. Domestic sales increased 9%. International sales increased 0.4%, reflecting operational growth of 3.7% and a negative currency impact of 3.3%. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 8.0%, domestic sales increased 11.6% and international sales increased 5.1%.
Alex Gorsky, chairman and CEO, said, “2014 was a strong year for Johnson & Johnson, as we delivered solid financial results while continuing to make investments to accelerate growth for the long term. He noted that among advances in other areas, “We are continuing our market leadership with iconic brands in our Consumer business.”
Worldwide Consumer sales of $14.5 billion for the full-year 2014 fell 1.4% from the prior year, due mostly to an operational increase of 1% and a negative impact from currency of 2.4%. Domestic sales decreased 1.3%; international sales decreased 1.4%, which reflected an operational increase of 2.3% and a negative currency impact of 3.7%. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 2.8%, domestic sales increased 3.1% and international sales increased 2.6%.
Positive contributors in the Consumer segment included Aveeno, Neutrogena, Dabao and Listerine.
Baby Care accounted for $2.2 billion ($407 million U.S.; $1.8 billion international) and fell a total of 2.2%; Oral Care reached $1.6 billion worldwide ($600 million in the U.S.; $1 billion internationally), a growth of 1.5%; and Skin Care reached $3.8 billion ($1.8 billion U.S.; $1.9 billion internationally), a worldwide growth of 1.5%. Notably, international sales fell by 1.4% but U.S. sales grew 4.7% for the year.
Neutrogena’s Hydro Boost range was a big hit with consumers, and marked the first time the brand brought its Asian technology to the U.S. marketplace. The hydration-centric Hydro Boost line consists of 10 SKUs in Asia, and J&J is gradually introducing the products in the U.S.
New Brunswick, NJ
www.jnj.com
Corporate Sales: $74.3 billion
Beauty Sales: $7.9 billion (skin care, baby care, oral care)
Key Personnel: Alex Gorsky, chairman, board of directors and chief executive officer; Dominic J. Caruso, chief financial officer; Jorge Mesquita, worldwide chairman, consumer.
Major Products/Brands: Neutrogena, Aveeno, Listerine, Johnson’s Baby, Dabao.
New Products: Aveeno Daily Moisturizing Sheer Hydration Lotion, Aveeno Baby Continuous Protection Lotion Sunscreen with Broad Spectrum SPF 55, Neutrogena Hydro Boost Water Gel, Neutrogena Healthy Skin Blush, Johnson’s Baby Head to Toe Wash, Johnson’s Baby Cologne, Listerine Naturals Rinse.
Comments: While primarily a pharmaceutical company, Johnson & Johnson’s select few consumer beauty brands are an additional shot in the arm for the New Jersey-based company—which scored the very healthy No. 6 slot on our Top 20 list.
Neutrogena’s Hydro Boost Collection brought Asian technology to the U.S. marketplace.
Alex Gorsky, chairman and CEO, said, “2014 was a strong year for Johnson & Johnson, as we delivered solid financial results while continuing to make investments to accelerate growth for the long term. He noted that among advances in other areas, “We are continuing our market leadership with iconic brands in our Consumer business.”
Worldwide Consumer sales of $14.5 billion for the full-year 2014 fell 1.4% from the prior year, due mostly to an operational increase of 1% and a negative impact from currency of 2.4%. Domestic sales decreased 1.3%; international sales decreased 1.4%, which reflected an operational increase of 2.3% and a negative currency impact of 3.7%. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 2.8%, domestic sales increased 3.1% and international sales increased 2.6%.
Positive contributors in the Consumer segment included Aveeno, Neutrogena, Dabao and Listerine.
Baby Care accounted for $2.2 billion ($407 million U.S.; $1.8 billion international) and fell a total of 2.2%; Oral Care reached $1.6 billion worldwide ($600 million in the U.S.; $1 billion internationally), a growth of 1.5%; and Skin Care reached $3.8 billion ($1.8 billion U.S.; $1.9 billion internationally), a worldwide growth of 1.5%. Notably, international sales fell by 1.4% but U.S. sales grew 4.7% for the year.
Neutrogena’s Hydro Boost range was a big hit with consumers, and marked the first time the brand brought its Asian technology to the U.S. marketplace. The hydration-centric Hydro Boost line consists of 10 SKUs in Asia, and J&J is gradually introducing the products in the U.S.
